Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women.

Carcinogenesis - 1 Mar 2013

Chen Kuan-Yu, Hsiao Chin-Fu, Chang Gee-Chen, Tsai Ying-Huang, Su Wu-Chou, Chen Yuh-Min, Huang Ming-Shyan, Hsiung Chao A, Chen Chien-Jen, Yang Pan-Chyr

Abstract excerpt

Hormone replacement therapy (HRT) and epidermal growth factor receptor (EGFR) single nucleotide polymorphisms (SNPs) have been reported as risk factors for lung cancer in never smokers. We investigate the interaction of EGFR SNPs and HRT for lung adenocarcinoma risk in never-smoking women. This study included 532 never-smoking female lung adenocarcinoma patients and 532 controls, with EGFR SNPs retrieved from a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Estrogen Replacement Therapy

Share to Multivariate Analysis

Share to Postmenopause

Share to Progestins

Share to Smoking

Source

Identifiers

PMID: 23239743
DOI: 10.1093/carcin/bgs385

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women.PMID 23239743Read ↗

Estrogen Receptor Gene Polymorphisms and Lung Adenocarcinoma Risk in Never-Smoking Women.Semantic proximity Read ↗

Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients.Semantic proximity Read ↗

Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population.Semantic proximity Read ↗

Genetic Polymorphism, Telomere Biology and Non-Small Lung Cancer Risk.Semantic proximity Read ↗

Plausible Role of Estrogens in Pathogenesis, Progression and Therapy of Lung CancerSemantic proximity Read ↗

Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in women.Semantic proximity Read ↗

Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among WomenSemantic proximity Read ↗

Association between sex hormones regulation-related SNP rs12233719 and lung cancer risk among never-smoking Chinese women.Semantic proximity Read ↗

Specificities of lung adenocarcinoma in women who have never smoked.Semantic proximity Read ↗

Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.Semantic proximity Read ↗

The Impact of Estrogen Receptor Expression on Mutational Status in the Evolution of Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.